People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eyevance Holdings LLC | — | Other | Series B | $30.0M | $498.6M | 2019 |
| Victory Pharma Inc | — | Pharmaceuticals | Series A | $10.0M | $309.7M | 2009 |
Matthew Heck at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Heck on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Parker | 1 | 11 |
| David Snyder | 1 | 5 |
| Scott Barry | 1 | 4 |
| Thomas Vandervort | 1 | 4 |
| Jason Werner | 1 | 3 |
| Herbert Hooper | 1 | 3 |
| Thomas Wiggans | 1 | 3 |
| Wes Brazell | 1 | 2 |
| James Flexner | 1 | 2 |
| James Newman | 1 | 2 |
| Terence Cook | 1 | 1 |
| Daniel Stokely | 1 | 1 |
| Jerry St. Peter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.